Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
86.42
Nov 13 • 12:38 PM ET Dollar change+0.28 Percentage change(0.32%)
Index
S&P 500, RUI
Market Cap
9.55B
Enterprise Value
14.83B
Income
421.00M
Sales
13.73B
Book/sh
28.58
Cash/sh
1.66
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
25000
IPO
Nov 03, 1995
P/E
23.65
Forward P/E
14.38
PEG
1.46
P/S
0.70
P/B
3.02
P/C
51.91
P/FCF
17.09
EV/EBITDA
12.83
EV/Sales
1.08
Quick Ratio
0.76
Current Ratio
1.33
Debt/Eq
1.23
LT Debt/Eq
0.85
Option/Short
Yes / Yes
EPS (ttm)
3.65
EPS next Y
6.01
EPS next Q
1.41
EPS this Y
11.01%
EPS next Y
8.96%
EPS next 5Y
9.86%
EPS past 3/5Y
-5.75% 3.12%
Sales past 3/5Y
1.40% 5.43%
EPS Y/Y TTM
15.68%
Sales Y/Y TTM
6.15%
EPS Q/Q
26.71%
Sales Q/Q
3.95%
Insider Own
15.46%
Insider Trans
0.00%
Inst Own
99.54%
Inst Trans
0.54%
ROA
3.72%
ROE
12.91%
ROIC
7.22%
Gross Margin
29.58%
Oper. Margin
5.99%
Profit Margin
3.07%
SMA20
0.69%
SMA50
0.58%
SMA200
6.00%
Trades
Shs Outstand
110.54M
Shs Float
93.45M
52W High
92.18 -6.25%
52W Low
68.70 25.79%
Volatility
3.23% 2.95%
ATR (14)
2.55
RSI (14)
50.76
Beta
0.86
Rel Volume
1.99
Avg Volume
1.25M
Volume
1,266,531
Perf Week
0.42%
Perf Month
-0.66%
Perf Quarter
-3.47%
Perf Half Y
18.83%
Perf YTD
14.34%
Perf Year
17.83%
Perf 3Y
28.02%
Perf 5Y
9.04%
Perf 10Y
40.72%
Prev Close
86.14
Price
86.42
Change %
0.32%
Consensus
Buy
Avg. Price Target
$96.60
Implied Upside
+11.8%
Analysts15incl. previous ratings
Rating Distribution8 Buy · 7 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jul 09, 2026Initiated
BMO logoBBMO Capital Markets
Market Perform$85-1.6%
Jun 11, 2026Upgrade
BBTIG Research
Neutral → Buy$100+15.7%
Apr 16, 2026Initiated
BBTIG Research
Neutral
Apr 15, 2026Initiated
C logoCCitigroup
Buy$100+15.7%
Feb 23, 2026Upgrade
RRobert W. Baird
Neutral → Outperform$100+15.7%
Dec 09, 2025Initiated
BCS logoBBarclays
Overweight$86-0.5%
Aug 26, 2025Upgrade
EVR logoEEvercore ISI
In-line → Outperform$83-4.0%
Jul 25, 2025Downgrade
SF logoSStifel
Buy → Hold$75-13.2%
Jul 14, 2025Downgrade
RRobert W. Baird
Outperform → Neutral$72-16.7%
Feb 14, 2025Initiated
WFC logoWWells Fargo
Equal Weight$80-7.4%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stanley M. BergmanFormer AffiliateAug 14 '26Proposed Sale90.1235,2573,177,361Aug 14 06:43 PM
HERRING JOSEPH LFormer DirectorJun 30 '26Proposed Sale84.2928,7912,426,793Jun 30 09:49 AM
Stanley M. BergmanAffiliateJun 16 '26Proposed Sale81.0916,9331,373,097Jun 16 05:07 PM
DANIEL WILLIAM KDirectorMay 11 '26Buy69.1910,000691,90020,000May 12 04:15 PM
Popeck Thomas CCEO, Henry Schein ProductsMar 19 '26Sale72.791,35598,63086,182Mar 20 04:07 PM
Popeck Thomas COfficerMar 19 '26Proposed Sale72.791,35598,630Mar 19 12:30 PM
KUEHN KURT PDirectorMar 10 '26Sale78.962,844224,56515,420Mar 11 04:08 PM
KUEHN KURT PDirectorMar 10 '26Proposed Sale78.962,844224,565Mar 10 01:42 PM
MLOTEK MARK EEVP, Chief Strategic OfficerMar 04 '26Sale80.805,925478,74080,554Mar 06 06:08 PM
LASKAWY PHILIP ADirectorMar 05 '26Sale80.362,844228,54421,961Mar 06 05:08 PM
LASKAWY PHILIP ADirectorMar 05 '26Proposed Sale80.362,844228,544Mar 05 12:40 PM
MLOTEK MARK EOfficerMar 04 '26Proposed Sale80.805,925478,739Mar 04 04:28 PM
BERGMAN STANLEY MChairman, CEOMar 02 '26Sale81.3143,8123,562,354383,803Mar 03 08:18 AM
Stanley M. BergmanCEO, ChairmanMar 02 '26Proposed Sale82.3943,8123,609,671Mar 02 06:31 PM
BERGMAN STANLEY MChairman, CEOFeb 26 '26Sale81.0138,3463,106,591427,615Feb 27 04:31 PM
BERGMAN STANLEY MChairman, CEOFeb 27 '26Sale81.2010,785875,742309,092Feb 27 04:31 PM
Stanley M. BergmanCEO, ChairmanFeb 27 '26Proposed Sale81.4710,785878,654Feb 27 04:22 PM
Stanley M. BergmanOfficerFeb 26 '26Proposed Sale81.9143,0463,525,898Feb 26 04:25 PM
Siegel WalterOfficerNov 17 '25Proposed Sale71.304,176297,749Nov 17 10:29 AM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the following segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The Global Distribution and Value-Added Services segment focuses on distribution to the global dental and medical markets of national brand and corporate brand merchandise, and equipment and related technical services. The Global Specialty Products segment includes manufacturing, marketing and sales of dental implant and biomaterial products, endodontic, orthodontic and orthopedic products. The Global Technology segment focuses on development and distribution of practice management software, e-services, and other products, which are distributed to health care providers. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
CEOFrederick M. Lowery